Life
Colorado Legislation Targets Orphan Drug Pricing Exemption
A proposed bill in Colorado aims to exempt orphan drugs from potential state-imposed pricing caps, reflecting ongoing tensions in pharmaceutical pricing policy.
Editorial Staff
1 min read
The Colorado legislature is currently considering a bill that would specifically exempt orphan drugs from any pricing limits that the state may implement.
This move comes amid broader discussions on pharmaceutical pricing and access, particularly for drugs that treat rare diseases.
The implications of this legislation could significantly affect the market dynamics for orphan drugs, influencing both pricing strategies and patient access.